Impact of comorbidities on risk of angioedema without urticaria in elderly patients

Abstract Background Angioedema without urticaria (AWU) is a disease found in the elderly population but is still poorly studied. The aim of this study was to investigate potential factors, especially comorbidities, that may affect the induction of angioedema without urticaria in patients over 60 yea...

Full description

Bibliographic Details
Main Authors: Andrzej Bożek, Magdalena Zając
Format: Article
Language:English
Published: BMC 2021-12-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Online Access:https://doi.org/10.1186/s13223-021-00637-z
_version_ 1831811769623904256
author Andrzej Bożek
Magdalena Zając
author_facet Andrzej Bożek
Magdalena Zając
author_sort Andrzej Bożek
collection DOAJ
description Abstract Background Angioedema without urticaria (AWU) is a disease found in the elderly population but is still poorly studied. The aim of this study was to investigate potential factors, especially comorbidities, that may affect the induction of angioedema without urticaria in patients over 60 years of age. Methods This was an observational, retrospective study of 242 patients with a diagnosis of AWU and 263 controls. The inclusion criteria were as follows: at least one episode of confirmed AWU based on the ICD-10 code (T78.3) that required treatment in the last 15 years (2004–2019); age above 60 years; detailed medical history of comorbidities; and details regarding the use of drugs at that time. Serum functional and quantitative C1 inhibitor assays were performed, and serum C4 was measured. Comorbidities were grouped into the following panels: autoimmune, cancer, cardiac, metabolic, respiratory and allergic, liver failure and renal failure. Individual diseases were checked according to ICD code and treatment. Results In 1 (0.4%) patient, hereditary angioedema was confirmed. Decreased levels of C1INH were observed in 4 (1.65%) patients, dysfunction of C1INH was observed in 5 (1.76%) patients, and low levels of C4 were observed in 9 (3.71%) patients in the study group. The multiple logistic regression model revealed that patients with hyperuricemia or Hashimoto’s disease had a significantly higher chance of angioedema (OR = 3.21, 95% CI 2.92–3.66, p = 0.002; OR = 1.78 95% CI 1.37–2.21, p = 0.034, respectively). Conclusion The obtained results may indicate a significant influence of hyperuricemia or Hashimoto’s disease on angioedema manifestations.
first_indexed 2024-12-22T21:24:01Z
format Article
id doaj.art-a0436419fe7142708e11468c38c6e9fb
institution Directory Open Access Journal
issn 1710-1492
language English
last_indexed 2024-12-22T21:24:01Z
publishDate 2021-12-01
publisher BMC
record_format Article
series Allergy, Asthma & Clinical Immunology
spelling doaj.art-a0436419fe7142708e11468c38c6e9fb2022-12-21T18:12:06ZengBMCAllergy, Asthma & Clinical Immunology1710-14922021-12-011711610.1186/s13223-021-00637-zImpact of comorbidities on risk of angioedema without urticaria in elderly patientsAndrzej Bożek0Magdalena Zając1Clinical Department of Internal Disease, Dermatology and Allergology, Medical University of SilesiaWroclaw Medical UniversityAbstract Background Angioedema without urticaria (AWU) is a disease found in the elderly population but is still poorly studied. The aim of this study was to investigate potential factors, especially comorbidities, that may affect the induction of angioedema without urticaria in patients over 60 years of age. Methods This was an observational, retrospective study of 242 patients with a diagnosis of AWU and 263 controls. The inclusion criteria were as follows: at least one episode of confirmed AWU based on the ICD-10 code (T78.3) that required treatment in the last 15 years (2004–2019); age above 60 years; detailed medical history of comorbidities; and details regarding the use of drugs at that time. Serum functional and quantitative C1 inhibitor assays were performed, and serum C4 was measured. Comorbidities were grouped into the following panels: autoimmune, cancer, cardiac, metabolic, respiratory and allergic, liver failure and renal failure. Individual diseases were checked according to ICD code and treatment. Results In 1 (0.4%) patient, hereditary angioedema was confirmed. Decreased levels of C1INH were observed in 4 (1.65%) patients, dysfunction of C1INH was observed in 5 (1.76%) patients, and low levels of C4 were observed in 9 (3.71%) patients in the study group. The multiple logistic regression model revealed that patients with hyperuricemia or Hashimoto’s disease had a significantly higher chance of angioedema (OR = 3.21, 95% CI 2.92–3.66, p = 0.002; OR = 1.78 95% CI 1.37–2.21, p = 0.034, respectively). Conclusion The obtained results may indicate a significant influence of hyperuricemia or Hashimoto’s disease on angioedema manifestations.https://doi.org/10.1186/s13223-021-00637-zAngioedemaElderlyIgEHyperuricemiaHashimoto
spellingShingle Andrzej Bożek
Magdalena Zając
Impact of comorbidities on risk of angioedema without urticaria in elderly patients
Allergy, Asthma & Clinical Immunology
Angioedema
Elderly
IgE
Hyperuricemia
Hashimoto
title Impact of comorbidities on risk of angioedema without urticaria in elderly patients
title_full Impact of comorbidities on risk of angioedema without urticaria in elderly patients
title_fullStr Impact of comorbidities on risk of angioedema without urticaria in elderly patients
title_full_unstemmed Impact of comorbidities on risk of angioedema without urticaria in elderly patients
title_short Impact of comorbidities on risk of angioedema without urticaria in elderly patients
title_sort impact of comorbidities on risk of angioedema without urticaria in elderly patients
topic Angioedema
Elderly
IgE
Hyperuricemia
Hashimoto
url https://doi.org/10.1186/s13223-021-00637-z
work_keys_str_mv AT andrzejbozek impactofcomorbiditiesonriskofangioedemawithouturticariainelderlypatients
AT magdalenazajac impactofcomorbiditiesonriskofangioedemawithouturticariainelderlypatients